Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study

Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study

Background/Aims: The efficacy and safety of vedolizumab in moderate-to-severely active Crohn's disease (CD) were demonstrated in the GEMINI 2 study (NCT00783692). This post-hoc exploratory analysis aimed to assess the efficacy and safety of vedolizumab in the subgroup of patients from Asian cou...

Full description

Saved in:
Bibliographic Details
Main Authors: Banerjee, Rupa, Chuah, Sai Wei, Hilmi, Ida Normiha, Wu, Deng-Chyang, Yang, Suk-Kyun, Demuth, Dirk, Lindner, Dirk, Adsul, Shashi
Format: Article
Published: Korean Assoc Study Intestinal Diseases 2021
Subjects:
RC Internal medicine
Online Access:http://eprints.um.edu.my/34972/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya

Internet

http://eprints.um.edu.my/34972/

Similar Items